
- RIUMA Principal
- Listar por autor
Listar por autor "Fernández-de-Las-Peñas, César"
Mostrando ítems 1-3 de 3
-
Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine
Nijs, Jo; George, Steven Z; Clauw, Daniel J; Fernández-de-Las-Peñas, César; Kosek, Eva; Ickmans, Kelly; Fernández-Carnero, Josué; Polli, Andrea; Kapreli, Eleni; Huysmans, Eva; Cuesta-Vargas, Antonio; Mani, Ramakrishnan; Lundberg, Mari; Leysen, Laurence; Rice, David; Sterling, Michele; Curatolo, Michele[et al.] (Elsevier, 2021-05)
Chronic pain is a leading cause of disability globally and associated with enormous health-care costs. The discrepancy between the extent of tissue damage and the magnitude of pain, disability, and associated symptoms ... -
Hydrotherapy as a recovery strategy after exercise: a pragmatic controlled trial
Cuesta-Vargas, Antonio; Travé-Mesa, Álvaro; Vera-Cabrera, Alberto; Cruz-Terrón, Dario; Castro-Sánchez, Adelaida María; Fernández-de-Las-Peñas, César; Arroyo Morales, Manuel[et al.] (BMC Springer Nature, 2013-07-18)
Background: Our aim was to evaluate the recovery effects of hydrotherapy after aerobic exercise in cardiovascular, performance and perceived fatigue. Methods: A pragmatic controlled repeated measures; single-blind trial ... -
Towards precision pain medicine for pain after cancer: the Cancer Pain Phenotyping Network multidisciplinary international guidelines for pain phenotyping using nociplastic pain criteria.
Nijs, Jo; Lahousse, Astrid; Fernández-de-Las-Peñas, César; Madeleine, Pascal; Fontaine, Christel; Nishigami, Tomohiko; Desmedt, Christine; Vanhoeij, Marian; Mostaqim, Kenza; Cuesta-Vargas, Antonio; Kapreli, Eleni; Bilika, Paraskevi; Polli, Andrea; Leysen, Laurence; Elma, Ömer; Roose, Eva; Rheel, Emma; Tümkaya Yılmaz, Sevilay; Liesbet, De Baets; Huysmans, Eva; Turk, Ali; Saraçoğlu, İsmail[et al.] (Elsevier, 2023-05)
Pain after cancer remains underestimated and undertreated. Precision medicine is a recent concept that refers to the ability to classify patients into subgroups that differ in their susceptibility to, biology, or prognosis ...